Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Brain Research|April 3, 2020
Antinociceptive effects of potent, selective and brain penetrant muscarinic M<sub>4</sub> positive allosteric modulators in rodent pain modelsSteven M Grauer, Raul Sanoja, Dominic Poulin, et al.
Psychopharmacology|December 25, 2010
AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodentsMark D Black, Rachel J Stevens, Nancy Rogacki, et al.
Scientific Reports|October 14, 2016
The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophreniaGuy Griebel, Philippe Pichat, Denis Boulay, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 2012
SAR110894, a potent histamine H₃-receptor antagonist, displays procognitive effects in rodentsGuy Griebel, Philippe Pichat, Marie-Pierre Pruniaux, et al.
Experimental Neurology|July 27, 2010
Preladenant, a selective A(2A) receptor antagonist, is active in primate models of movement disordersRobert A Hodgson, Paul J Bedard, Geoffrey B Varty, et al.
Psychopharmacology|February 1, 2005
The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profilesGeoffrey B Varty, Mariagrazia Grilli, Angelo Forlani, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 22, 2008
The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)Geoffrey B Varty, Sherry X Lu, Cynthia A Morgan, et al.
European Journal of Pharmacology|May 7, 2011
The anxiolytic-like profile of the nociceptin receptor agonist, endo-8-[bis(2-chlorophenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octane-3-carboxamide (SCH 655842): comparison of efficacy and side effects across rodent speciesSherry X Lu, Guy A Higgins, Robert A Hodgson, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 2009
Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depressionRobert A Hodgson, Rosalia Bertorelli, Geoffrey B Varty, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2009
Tetrahydroquinoline sulfonamides as vasopressin 1b receptor antagonistsJack D Scott, Michael W Miller, Sarah W Li, et al.
Pageof 4